|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| Choose application no.
|
|
| |
|
|
| Application no. and date | 08709412.4 (espacenet) (Federated) (European Patent Register), 20080215 | | Patent/reg. no. and date | DK/EP 2125019, 20140409 | | Publication date | 20091202 | | Priority no. and date | GB 0703966, 20070301 | | EP pub. no. and date |
EP 2125019 20091202 | | Effective date | | | Applicant/owner | RB Pharmaceuticals Limited, 103-105 Bath Road
Slough
Berkshire SL1 3UH, GB | | Applicant ref. no. | P20885DKEP | | Inventor | HYDE, Neil, Reckitt Benckiser Healthcare (UK) Limited
Dansom Lane
Hull HU8 7DS, GB,
CHAPLEO, Christopher, Bourne, Reckitt Benckiser Healthcare (UK) Limited
Dansom Lane
Hull HU8 7DS, GB | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | A61K 45/06 (2006.01) , A61P 25/04 (2006.01) | | Title | Forbedrede medicinsammensætninger omfattende buprenorfin og naltrexon | | Int. application no. | GB2008000521 | | Int. publication no. | WO2008104735 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
